Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia Ruiz

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
Clinical and Experimental Rheumatology|November 15, 2022
A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identificationMarta Novella-Navarro, Virginia Ruiz-Esquide, Gabriela Torres-Ortiz, et al.
Therapeutic Advances in Musculoskeletal Disease|October 13, 2022
Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritisMarta Novella-Navarro, Diego Benavent, Virginia Ruiz-Esquide, et al.
Rheumatology (Oxford, England)|July 13, 2020
Biomarkers for treatment change and radiographic progression in patients with rheumatoid arthritis in remission: a 5 year follow-up studyJulio Ramírez, Andrea Cuervo, Raquel Celis, et al.
The Journal of Rheumatology|August 3, 2019
Rheumatoid Arthritis Initiating as Palindromic Rheumatism: A Distinct Clinical Phenotype?Raul Castellanos-Moreira, Sebastian C Rodriguez-Garcia, José A Gómez-Puerta, et al.
The FEBS Journal|July 22, 2014
Proline-serine-threonine phosphatase interacting protein 1 inhibition of T-cell receptor signaling depends on its SH3 domainTamara Marcos, Virginia Ruiz-Martín, María Luisa de la Puerta, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced ArthritisAndrés Ponce, Beatriz Frade-Sosa, Juan C Sarmiento-Monroy, et al.
Seminars in Arthritis and Rheumatism|May 28, 2017
Clinical and sonographic biomarkers of structural damage progression in RA patients in clinical remission: A prospective study with 12 months follow-upJulio Ramírez, José Antonio Narváez, Virginia Ruiz-Esquide, et al.
Cell Reports|March 10, 2021
Most non-canonical proteins uniquely populate the proteome or immunopeptidomeMaria Virginia Ruiz Cuevas, Marie-Pierre Hardy, Jaroslav Hollý, et al.
Arthritis Research & Therapy|July 19, 2025
Early-onset difficult-to-treat rheumatoid arthritis: proposal of data-driven predictors and temporal thresholdPablo Rodriguez-Merlos, Jose Luis Cabrera-Alarcón, Virginia Ruiz-Esquide, et al.
Genome Biology|August 15, 2023
BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigensMaria Virginia Ruiz Cuevas, Marie-Pierre Hardy, Jean-David Larouche, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Clinical and Experimental Rheumatology|November 15, 2022
A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identificationMarta Novella-Navarro, Virginia Ruiz-Esquide, Gabriela Torres-Ortiz, et al.
Therapeutic Advances in Musculoskeletal Disease|October 13, 2022
Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritisMarta Novella-Navarro, Diego Benavent, Virginia Ruiz-Esquide, et al.
Rheumatology (Oxford, England)|July 13, 2020
Biomarkers for treatment change and radiographic progression in patients with rheumatoid arthritis in remission: a 5 year follow-up studyJulio Ramírez, Andrea Cuervo, Raquel Celis, et al.
The Journal of Rheumatology|August 3, 2019
Rheumatoid Arthritis Initiating as Palindromic Rheumatism: A Distinct Clinical Phenotype?Raul Castellanos-Moreira, Sebastian C Rodriguez-Garcia, José A Gómez-Puerta, et al.
The FEBS Journal|July 22, 2014
Proline-serine-threonine phosphatase interacting protein 1 inhibition of T-cell receptor signaling depends on its SH3 domainTamara Marcos, Virginia Ruiz-Martín, María Luisa de la Puerta, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced ArthritisAndrés Ponce, Beatriz Frade-Sosa, Juan C Sarmiento-Monroy, et al.
Seminars in Arthritis and Rheumatism|May 28, 2017
Clinical and sonographic biomarkers of structural damage progression in RA patients in clinical remission: A prospective study with 12 months follow-upJulio Ramírez, José Antonio Narváez, Virginia Ruiz-Esquide, et al.
Cell Reports|March 10, 2021
Most non-canonical proteins uniquely populate the proteome or immunopeptidomeMaria Virginia Ruiz Cuevas, Marie-Pierre Hardy, Jaroslav Hollý, et al.
Arthritis Research & Therapy|July 19, 2025
Early-onset difficult-to-treat rheumatoid arthritis: proposal of data-driven predictors and temporal thresholdPablo Rodriguez-Merlos, Jose Luis Cabrera-Alarcón, Virginia Ruiz-Esquide, et al.
Genome Biology|August 15, 2023
BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigensMaria Virginia Ruiz Cuevas, Marie-Pierre Hardy, Jean-David Larouche, et al.
Pageof 14